Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-Enhanced Virtual Reality Cognitive Behavioral Therapy to Reduce Anxiety and Improve Quality of Life in Patients With Inflammatory Bowel Disease: A Multicenter Pilot and Feasibility Study

NCT07590518 is registered in ClinicalTrials.gov with Brennan Spiegel as lead sponsor.

NCT NCT07590518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07590518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-Enhanced Virtual Reality Cognitive Behavioral Therapy to Reduce Anxiety and Improve Quality of Life in Patients With Inflammatory Bowel Disease: A Multicenter Pilot and Feasibility Study
Lead sponsor
Brennan Spiegel
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
July 31, 2027
Enrollment
76 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, crohn disease (cd), inflammatory bowel disease (ibd), ulcerative colitis (uc)